|
|
Article: Schering-Plough Aims To Make CLARITIN(R) Premier Brand In OTC Category, Establish CLARINEX(R) As Premier Brand In Prescription Category.
- Article from:
- PR Newswire
- Article date:
- March 8, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Company Reports FDA Accepts Filings of Applications
To Market CLARITIN Line as OTC Antihistamines
KENILWORTH, N.J., March 8 /PRNewswire/ Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing supplemental New Drug Applications (sNDAs) to switch all indications and market all formulations of the company's CLARITIN(R) (loratadine) brand of nonsedating antihistamine as over-the-counter (OTC) products.
"With the market introduction of CLARINEX(R) as the first and only prescription nonsedating antihistamine approved for the treatment of indoor and outdoor allergies, moving ...